Posterior Reversible Encephalopathy Syndrome in a Pediatric COVID-19 Patient

KORKMAZER B., Ozogul M., HIKMAT E., KILIÇ H., AYGÜN F., ARSLAN S., ...More

PEDIATRIC INFECTIOUS DISEASE JOURNAL, vol.40, no.6, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 40 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.1097/inf.0000000000003130
  • Journal Name: PEDIATRIC INFECTIOUS DISEASE JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Istanbul University Affiliated: No

Abstract

Novel coronavirus disease 2019 is a viral infectious disease which commonly involve the lungs with primarily radiologic manifestations of atypical or organizing pneumonia. It can cause multisystemic involvement including central nervous system symptoms. One of these neurologic manifestations is posterior reversible encephalopathy syndrome (PRES). It is suggested that the increased levels of cytokines and inflammatory mediators in the course of the disease are responsible for cerebrovascular endothelial dysfunction and disruption of the blood-brain barrier. To the best of our knowledge, no pediatric PRES has been reported related to coronavirus disease 2019. Here, we present a pediatric PRES case associated with severe acute respiratory syndrome coronavirus 2 infection.